(Q79761766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

secondary hyperparathyroidism

25 December 2019

main subject

1 reference

K Shiizaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

I Hatamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Negi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Sakaguchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

F Saji

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

K Kunimoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Okamoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

I Imazeki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Y Muragaki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Akizawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

21 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

486-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16788697%20AND%20SRC:MED&resulttype=core&format=json

Arterial calcifications and bone histomorphometry in end-stage renal disease

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Regulation of parathyroid hormone synthesis in chronic renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Elective total parathyroidectomy without autotransplant in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001564

7 January 2021